These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8718466)

  • 21. New combined hepatitis A and B vaccine. Risks Of viral hepatitis related to travel.
    Zuckerman JN
    BMJ; 1998 Apr; 316(7140):1317. PubMed ID: 9554910
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combined hepatitis A/B immunization in children and adolescents. Economic evaluation of different immunization methods].
    Smala AM; Szucs TD; Berger K; Windorfer A
    MMW Fortschr Med; 1999 Jun; 141(23):55-6. PubMed ID: 10468485
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adult-onset Still's disease after hepatitis A and B vaccination?].
    Grasland A; Le Maître F; Pouchot J; Hazera P; Bazin C; Vinceneux P
    Rev Med Interne; 1998 Feb; 19(2):134-6. PubMed ID: 9775130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New combined hepatitis A and B vaccine. Immunisation is only part of preventing infectious disease.
    Kasianos G
    BMJ; 1998 Apr; 316(7140):1317. PubMed ID: 9599052
    [No Abstract]   [Full Text] [Related]  

  • 25. New combined hepatitis A and B vaccine. New vaccine is an adjunct, not an alternative to preventive behaviours.
    Birthistle K; Benbow A
    BMJ; 1998 Apr; 316(7140):1317-8. PubMed ID: 9599053
    [No Abstract]   [Full Text] [Related]  

  • 26. Leads from the MMWR. Recommendations of the immunization practices advisory committee update on hepatitis B prevention.
    JAMA; 1987 Jul 24-31; 258(4):437, 444-5, 449. PubMed ID: 2955136
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Romanò L; Paladini S; Tagliacarne C; Zappa A; Zanetti AR
    Vaccine; 2009 May; 27(25-26):3439-42. PubMed ID: 19200848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal vaccination against hepatitis B.
    CMAJ; 1992 Jan; 146(1):36. PubMed ID: 1530817
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis A and vaccination.
    Teuwen DE
    Arch Inst Pasteur Tunis; 1994; 71(3-4):549-56. PubMed ID: 8801857
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B vaccines: use in childhood.
    Moyes CD
    N Z Med J; 1988 Apr; 101(843):165-6. PubMed ID: 2965800
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccines released.
    Am J Infect Control; 1995 Jun; 23(3):213. PubMed ID: 7677269
    [No Abstract]   [Full Text] [Related]  

  • 33. Committee on Native American Child Health and Committee on Infectious Diseases. Immunizations for Native American children. American Academy of Pediatrics.
    Pediatrics; 1999 Sep; 104(3 Pt 1):564-7. PubMed ID: 10469787
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The federal health office on viral hepatitis: incidence reporting responsibility and preventive vaccination].
    Moll H
    Monatsschr Kinderheilkd; 1989 Sep; 137(9):623. PubMed ID: 2530439
    [No Abstract]   [Full Text] [Related]  

  • 36. [The present and future of vaccination against hepatitis B].
    Horton J
    Cas Lek Cesk; 1986 Dec; 125(52):1593-4. PubMed ID: 2948650
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatitis A vaccination: a sensible luxury?].
    Holzer RB
    Schweiz Rundsch Med Prax; 1993 Feb; 82(7):183-5. PubMed ID: 8382372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B immunisation.
    Kuttner J
    N Z Med J; 1988 May; 101(845):244-5. PubMed ID: 2966906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.